1 |
Tong Y, Zhang S, Riddle S, Song R, Yue D. Circular RNAs in the Origin of Developmental Lung Disease: Promising Diagnostic and Therapeutic Biomarkers. Biomolecules 2023;13:533. [DOI: 10.3390/biom13030533] [Reference Citation Analysis]
|
2 |
Alva R, Mirza M, Baiton A, Lazuran L, Samokysh L, Bobinski A, Cowan C, Jaimon A, Obioru D, Al Makhoul T, Stuart JA. Oxygen toxicity: cellular mechanisms in normobaric hyperoxia. Cell Biol Toxicol. [DOI: 10.1007/s10565-022-09773-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Bao T, Zhu H, Ma M, Sun T, Hu J, Li J, Cao L, Cheng H, Tian Z. Implication of m6A methylation regulators for the immune microenvironment of bronchopulmonary dysplasia.. [DOI: 10.21203/rs.3.rs-2046982/v1] [Reference Citation Analysis]
|
4 |
Kang H, Yu H, Zeng L, Ma H, Cao G. LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis. Hypertens Res 2022. [PMID: 35264782 DOI: 10.1038/s41440-022-00884-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
5 |
Ashrafizadeh M, Zarrabi A, Mostafavi E, Aref AR, Sethi G, Wang L, Tergaonkar V. Non-coding RNA-based regulation of inflammation. Semin Immunol 2022;59:101606. [PMID: 35691882 DOI: 10.1016/j.smim.2022.101606] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
6 |
Sakaria RP, Dhanireddy R. Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence? Front Pediatr 2022;10:820259. [PMID: 35356441 DOI: 10.3389/fped.2022.820259] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|